SAM
AGN

S.A. Mason’s Allergan plc AGN Stock Holding History

S.A. Mason’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-264
Closed -$47K – 396
2020
Q1 		$47K Hold
264
– – 0.06% 210
2019
Q4 		$50K Buy
+264
New +$47.6K 0.05% 228

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

S.A. Mason's AGN Position: Q2 2020 in Review

S.A. Mason sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 264 shares — an estimated $47K sold.

S.A. Mason first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $50K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • S.A. Mason reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • S.A. Mason sold 264 Allergan plc shares in Q2 2020, an estimated $47K.
  • S.A. Mason first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • S.A. Mason's Allergan plc position peaked at $50K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on S.A. Mason's 13F filing for Q2 2020, filed 27 Jul 2020.